Clinical Trial Update: Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source [Phase 1, Phase 2]

View source ↗

Summary

An initial feasibility study (Phase 1/Phase 2) is evaluating a planar low-dose-rate (LDR) source to treat borderline resectable pancreatic cancer, with recruitm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: CivaTech Oncology | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: RECRUITING